BCRX - BIOCRYST PHARMACEUTICALS INC

QQQ $ 441.71 $ 1.04 (0.24 %)

DIA $ 395.04 $ 1.18 (0.3 %)

SPY $ 520.76 $ 0.67 (0.13 %)

TLT $ 90.14 $ -0.51 (-0.56 %)

GLD $ 218.73 $ 1.76 (0.81 %)

Previous Close

$ 5.32

Open

$ 5.45

Bid

$ 5.32 x 700

Ask

$ 5.33 x 1,300

Day's Range

$ 5.24 - $ 5.77

52 Week Range

$ 4.03 - $ 8.96

Volume

3,502,122

Average Volume

Market Cap

1.1B

Beta (5Y Monthly)

$ 0.89

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-07-2024	03-31-2024	10-Q
2	02-27-2024	12-31-2023	10-K
3	11-08-2023	09-30-2023	10-Q
4	08-07-2023	06-30-2023	10-Q
5	05-08-2023	03-31-2023	10-Q
6	02-27-2023	12-31-2022	10-K
7	11-04-2022	09-30-2022	10-Q
8	08-05-2022	06-30-2022	10-Q
9	05-09-2022	03-31-2022	10-Q
10	02-28-2022	12-31-2021	10-K
11	11-04-2021	09-30-2021	10-Q
12	08-09-2021	06-30-2021	10-Q
13	05-07-2021	03-31-2021	10-Q
14	03-01-2021	12-31-2020	10-K
15	11-06-2020	09-30-2020	10-Q
16	08-10-2020	06-30-2020	10-Q
17	05-11-2020	03-31-2020	10-Q
18	03-13-2020	12-31-2019	10-K
19	11-08-2019	09-30-2019	10-Q
20	08-08-2019	06-30-2019	10-Q
21	05-09-2019	03-31-2019	10-Q
22	03-14-2019	12-31-2018	10-K
23	11-08-2018	09-30-2018	10-Q
24	08-09-2018	06-30-2018	10-Q
25	05-09-2018	03-31-2018	10-Q
26	03-12-2018	12-31-2017	10-K
27	11-08-2017	09-30-2017	10-Q
28	08-08-2017	06-30-2017	10-Q
29	05-08-2017	03-31-2017	10-Q
30	02-27-2017	12-31-2016	10-K
31	11-08-2016	09-30-2016	10-Q
32	08-08-2016	06-30-2016	10-Q
33	05-09-2016	03-31-2016	10-Q
34	02-26-2016	12-31-2015	10-K
35	11-06-2015	09-30-2015	10-Q
36	08-07-2015	06-30-2015	10-Q
37	05-08-2015	03-31-2015	10-Q
38	03-02-2015	12-31-2014	10-K
39	11-07-2014	09-30-2014	10-Q
40	08-08-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

BioCryst Presents New Real-world Evidence ...
05/09/2024 11:41:50

JMP Securities Maintains Market Outperform...
05/07/2024 15:29:42

JMP Securities analyst Jonathan Wolleben maintains BioCryst Pharma (NASDAQ:BCRX) with a Market Outperform and raises the pri...

HC Wainwright & Co. Reiterates Buy on BioC...
05/07/2024 10:16:41

HC Wainwright & Co. analyst Andrew Fein reiterates BioCryst Pharma (NASDAQ:BCRX) with a Buy and maintains $30 price target.

Needham Reiterates Buy on BioCryst Pharma,...
05/07/2024 09:33:05

Needham analyst Serge Belanger reiterates BioCryst Pharma (NASDAQ:BCRX) with a Buy and maintains $12 price target.

biocryst-pharmaceuticals-fantastic-q1-earnings-rides-on-outstanding-orladeyo-performance

BioCryst Pharmaceuticals 'Fantastic' Q1 Ea...
05/06/2024 18:59:35

BioCryst's impressive first-quarter earnings report surpasses estimates. Sales surged to $92.8 million, primarily driven by...

why-perficient-shares-are-trading-higher-by-around-53-here-are-20-stocks-moving-in-mondays-mid-day-session

Why Perficient Shares Are Trading Higher B...
05/06/2024 16:32:34

Biocryst Forecasts 2024 Orladeyo Revenue O...
05/06/2024 11:05:22

BioCryst Pharma Q1 2024 Adj EPS $(0.17) Be...
05/06/2024 11:03:10

BioCryst Pharmaceuticals Announced That Th...
04/17/2024 08:36:06

Needham Reiterates Buy on BioCryst Pharma,...
04/10/2024 11:10:05

Needham analyst Serge Belanger reiterates BioCryst Pharma (NASDAQ:BCRX) with a Buy and maintains $12 price target.

whats-going-on-with-biocryst-stock-after-earnings

What's Going On With BioCryst Stock After ...
02/26/2024 18:30:11

BioCryst reported quarterly losses of 28 cents per share, missing the analyst consensus estimate of losses of 24 cents by 16.67...

10-health-care-stocks-with-whale-alerts-in-todays-session

10 Health Care Stocks With Whale Alerts In...
02/26/2024 17:35:26

Li Auto Posts Q4 Earnings, Joins Teva Phar...
02/26/2024 12:03:47

U.S. stock futures were lower this morning, with the Dow futures trading lower by over 50 points on Monday.

BioCryst Forecasts Fiscal Year 2024 Orlade...
02/26/2024 12:02:59

BioCryst Pharma Q4 Adjusted EPS $(0.28) Mi...
02/26/2024 12:01:37

BioCryst Pharma (NASDAQ:BCRX) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0...

Earnings Scheduled For February 26, 2024
02/26/2024 09:47:53

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.23 per share on...

A Preview Of BioCryst Pharma's Earnings
02/23/2024 19:01:35

BioCryst Pharmaceuticals Says New Analyses...
02/23/2024 12:05:21

Reported Monday, BioCryst Launches ORLADEY...
02/20/2024 08:48:57

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the Italian Medicines Agency, Agenzia Italiana del Farmaco ...

why-rxsight-shares-are-trading-higher-by-20-here-are-other-stocks-moving-in-mondays-mid-day-session

Why RxSight Shares Are Trading Higher By 2...
01/08/2024 18:36:30

Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24...